White Lale 4
4 · Cardiff Oncology, Inc. · Filed Jul 6, 2022
Insider Transaction Report
Form 4
White Lale
Director
Transactions
- Exercise/Conversion
Common Stock
2022-07-05$2.60/sh+28,858$75,031→ 98,788 total(indirect: By Trust) - Exercise/Conversion
Stock Options
2022-07-05$2.60/sh−28,858$75,031→ 60,716 totalExercise: $2.60From: 2021-06-17Exp: 2030-06-17→ Common Stock (28,858 underlying)